CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

por Sychev, DA, Baturina, OA, Mirzaev, KB, Rytkin, E, Ivashchenko, DV, Andreev, DA, Ryzhikova, KA, Grishina, EA, Bochkov, PO, Shevchenko, RV
Publicado 2020